TL;DR
This paper systematically reviews and analyzes randomized controlled trials (RCTs) comparing different sedative agents for routine endoscopic procedures. It finds that moderate sedation generally leads to high patient and physician satisfaction with a low risk of serious adverse events, and that propofol offers shorter sedation and recovery times compared to midazolam-based regimens.
What Problem Does This Paper Address?
Routine endoscopic procedures like EGD (esophagogastroduodenoscopy) and colonoscopy are widely performed, and sedation is a common practice in many regions, particularly the US. However, there's a wide variation in sedation practices globally and even within the US, with no clear consensus on the optimal agents. This variability stems from factors like physician experience, patient expectations, financial considerations, and regulatory environments. The problem this paper addresses is the lack of a clear, evidence-based comparison of the efficacy, safety, and efficiency of various agents used for moderate sedation in these common procedures. Without this, clinicians and patients lack definitive guidance on the best sedation strategies.
Methods
The authors conducted a systematic review and meta-analysis of randomized controlled trials (RCTs). They searched major bibliographic databases (EMBASE and MEDLINE) for RCTs comparing at least two active sedative regimens or one active regimen against placebo/no sedation for moderate sedation in adults undergoing EGD or colonoscopy. Studies were excluded if they involved deep sedation, general anesthesia, oral agents, inhalational agents, or experimental drugs. The quality of included studies was assessed using the Jadad scale. Data abstraction included patient demographics, drug doses, adverse events, procedure times, and patient/physician assessments. Pooled analyses were performed using meta-analysis techniques (fixed-effects or random-effects models depending on heterogeneity) to calculate summary relative risks (RR) and confidence intervals (CI) for various outcomes.
Datasets
The "datasets" in this context are the 36 randomized controlled trials (RCTs) that met the inclusion criteria, encompassing a total of 3918 patients. These trials were sourced from published literature. No new datasets or benchmarks were introduced by the authors.
Key Insights and Ideas
- Sedation is Generally Beneficial: Sedation significantly improves patient satisfaction and willingness to repeat endoscopic procedures compared to no sedation. This highlights the value patients place on comfort during these procedures.
- Midazolam vs. Diazepam: Midazolam appears to be superior to diazepam for moderate sedation, offering better patient satisfaction and less frequent patient recall of the procedure. This suggests a preference for midazolam when choosing between these two common benzodiazepines.
- Propofol's Efficiency Edge: Propofol-based regimens, particularly propofol alone, lead to shorter sedation and recovery times compared to midazolam-based regimens. This efficiency gain could be significant for endoscopy unit throughput.
- Safety Profile: Moderate sedation, regardless of the agent, is associated with a low risk of serious adverse events. This is reassuring for both patients and clinicians.
- Memory vs. Satisfaction Trade-off: While midazolam offers better patient satisfaction and less memory of the procedure compared to diazepam, the meta-analysis also showed that midazolam plus narcotics led to more frequent memory recall compared to propofol. This suggests a nuanced relationship between amnesia and overall satisfaction.
- Methodological Limitations: A significant limitation is the marked variability in study designs, regimens tested, and outcome assessments across the included trials. Furthermore, a majority of the studies had relatively poor methodologic quality (Jadad score ≤3), which can impact the reliability of the findings.
Key Results
- Sedation vs. No Sedation: Sedation improved patient satisfaction (RR 2.29) and willingness to repeat EGD (RR 1.25) compared to no sedation.
- Midazolam vs. Diazepam: Midazolam provided superior patient satisfaction (RR 1.18) and less frequent memory of EGD (RR 0.57) compared to diazepam.
- Midazolam (+/- Narcotics) vs. Propofol: Adverse events and patient/physician assessments were generally not significantly different between midazolam (with or without narcotics) and propofol. However, midazolam plus narcotics was associated with slightly less patient satisfaction (RR 0.90) and more frequent memory recall (RR 3.00) compared to propofol.
- Procedure Times: Procedure times were similar across regimens, but sedation and recovery times were shorter with propofol than midazolam-based regimens.
- Study Quality: 23 out of 36 trials had Jadad scores of ≤3, indicating lower methodological quality.
Limitations and Future Work
The authors acknowledge several limitations:
- Variability in Study Design: Significant differences in study design, tested regimens, and outcome measures make direct comparisons challenging.
- Methodological Quality: A majority of the included studies had relatively poor methodological quality, which can affect the robustness of the findings.
- Limited Head-to-Head Comparisons: For some comparisons, the number of studies was limited, and direct head-to-head comparisons were not always available, making pooled results less definitive.
Future work suggested by the paper includes:
- Need for More RCTs: Further controlled trials are needed to compare sedation with combinations of propofol and midazolam or narcotics versus propofol alone or benzodiazepines plus narcotics.
- Impact of Propofol on Unit Efficiency: More research is needed to determine the true impact of propofol sedation on endoscopy unit efficiency.
- Role of Ultrathin Endoscopes: The potential for decreased sedation needs with the adoption of ultrathin endoscopes for EGD warrants further investigation.
- Understanding Memory: Further investigation into the importance of procedure memory in the patient sedation experience is needed.
Summary updated